MCMCB Pro
J1556

J1556Injection, immune globulin (bivigam), 500 mg

HCPCSActiveBETOS O1E

J1556 is a HCPCS Level II code for injection, immune globulin (bivigam), 500 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J1556 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
240 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
outpatient
240 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
DME supplier
240 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J1556

Long descriptor
Injection, immune globulin (bivigam), 500 mg

The official wording. This is what the code means.

Short descriptor
Inj, imm glob bivigam, 500mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2014

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J1556

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1556 is not quite right, the correct code is very often within a few positions of it.

  • J1458Injection, galsulfase, 1 mg
  • J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
  • J1460Injection, gamma globulin, intramuscular, 1 cc
  • J1551Injection, immune globulin (cutaquig), 100 mg
  • J1552Injection, immune globulin (alyglo), 500 mg
  • J1553Injection, immune globulin (yimmugo), 100 mg
  • J1554Injection, immune globulin (asceniv), 500 mg
  • J1555Injection, immune globulin (cuvitru), 100 mg
  • J1557Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
  • J1558Injection, immune globulin (xembify), 100 mg
  • J1559Injection, immune globulin (hizentra), 100 mg
  • J1560Injection, gamma globulin, intramuscular, over 10 cc
  • J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
  • J1562Injection, immune globulin (vivaglobin), 100 mgterminated
  • J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
  • J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg

Questions about J1556

What is HCPCS code J1556?

J1556 is a HCPCS Level II code for injection, immune globulin (bivigam), 500 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J1556?

The CMS HCPCS file marks J1556 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J1556 paid under the physician fee schedule?

J1556 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026